2025 annual financial data
Xenetic Biosciences 2025 Net margin
Direct answer
Net margin was -90.07%.
Operating income was -2.83M USD and net income was -2.68M USD.
Operating cash flow was -2.29M USD.
Get free Xenetic Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2.98M USD
- Operating income
- -2.83M USD
- Net income
- -2.68M USD
- Operating cash flow
- -2.29M USD